RFM Clinical Trials

Bioness, Inc

Bioness, Inc. is established and granted a license to use technology for rehabilitation applications.

2003

IMES

AMF, Illinois Institute of Technology and the Rehabilitation Institute of Chicago form a partnership to develop an Implantable MyoElectric Sensor (IMES) system that could be used to control prosthetic limbs

BION® Developed

AMF licenses microstimulator technology to Advanced Bionics for certain medical applications. Advanced Bionics develops a battery-powered microstimulator device called BION®, which is used in clinical trials for urinary incontinence. Boston Scientific later obtains this license and develops a BION® application to treat migraine headache

1999

BPM Implant

AMF begins development of a battery-powered microstimulator (BPM) implant, which will have a rechargeable battery, and high-speed two-way telemetry.

1996

MRG Formed

Medical Research Group (MRG) is formed to work on the long-term glucose sensor, one of AMF’s founding projects

1993

Advanced Bionics Formed

Advanced Bionics is formed and receives the license to manufacture and distribute the Clarion® Cochlear Implant

1991

Microstimulator

AMF and its partners deliver the first prototype of the implantable microstimulator device, which is powered and controlled using radio frequency (RF) and is encased in a glass capsule. A subsequent iteration of the RF-powered microstimulator (RFM) employs a stronger hermetic casing made of ceramic

1989

Neurostimulator

In collaboration with the Illinois Institute of Technology (IIT) and Queens University in Canada, AMF begins development of a miniature implantable neurostimulator device. AMF works on the hermetically sealed case, IIT on circuitry, and Queens on communication protocol

1986

Clarion® Cochlear Implant

Together with the University of California San Francisco and The Research Triangle Institute, AMF works on the enabling technology for what will become the Clarion® Cochlear Implant

1985

Alfred Mann Foundation Founded

Alfred Mann Foundation established to bridge basic research in medicine and to create products that filled unmet and poorly-met needs.